Statistics

Total Visits

Views
Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study27

Select a period of time:

Number of views in the range

Views
Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study17

Views

Views
October 20240
November 20240
December 20240
January 20251
February 20251
March 202515
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United Kingdom2
 

Top cities views

Views